School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.

Slides:



Advertisements
Similar presentations
The need to challenge unhealthy drug policies to improve drug treatment Dr Chris Ford, Holly Catania and Rebecca Murchie IDHDP.
Advertisements

Martin C. Donoghoe Programme Manager HIV/AIDS, STIs and Viral Hepatitis World Health Organization Regional Office for Europe Communicable disease control.
Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
GAP Report 2014 Sex workers People left behind: Sex workers Link with the pdf, Sex workers.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
Supporting community action on AIDS in developing countries MDG’s and the Law: Creating an Enabling Legislative Environment Anton Kerr Head of Policy –
Harmonizing public health and public safety in a politically conservative environment Joëlle Rabot Field Coordinator Collectif Urgence.
Topic 3 Strategies that help reduce the transmission of HIV Slide 3.1.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
…at what cost ? …at what cost ?. Ten year review:  Law enforcement at the expense of public health and human rights  Major HIV epidemics among IDU 
Opiate Substitution Treatment and Harm Reduction in prisons: the Geneva model PD Dr Hans Wolff University Hospitals Geneva
Drug policy and harm reduction: impact of the US policy Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
Louisa Degenhardt 1, Bradley Mathers 1, Peter Vickerman 2, Tim Rhodes 3, Carl Latkin 4 and Matt Hickman 5 1.National Drug and Alcohol Research Centre,
The Economics and Financing of Harm Reduction David Wilson and Nicole Fraser, Global HIV/AIDS Program, World Bank David Wilson, University of New South.
HIV, Drug Policy and Harm Reduction. Outreach in Moscow, Russia,1998.
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
HIV, drugs and the legal environment Steffanie A. Strathdee (University of California San Diego, La Jolla, CA, USA), Leo Beletsky (Northeastern University.
A Review of Barriers and Ways Forward Daniel Wolfe 1 Patrizia Carrieri 2 Donald Shepard 3 Paper 3 Treatment and Care for IDUS with HIV 1. Open Society.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
1 Current status of harm reduction in Asia International AIDS Conference, Toronto, August 2006 Mr Jimmy Dorabjee Macfarlane Burnet Institute, Melbourne,
1 Controlling HIV among injecting drug users: current status of harm reduction International AIDS Conference, Toronto, 15 August 2006 Dr. Alex Wodak, Sydney,
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
“Getting to Zero” UNAIDS Strategy Dr. Paul De Lay, Deputy Executive Director, Programme UNAIDS.
If I ruled the world… Presentation to Prisons and Beyond NOMS Prison Drug Strategy Unit, in association with the Federation of Drug & Alcohol Professionals.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
Cost-effectiveness of harm reduction David P Wilson.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Economic and policy dimensions of HIV in Eastern Europe and Central Asia David Wilson and Nicole Fraser, Global HIV/AIDS Program, World Bank David Wilson,
Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais,
How to improve law enforcement knowledge about HIV and to work with drug users and sex workers: experiences from Kyrgyzstan Aleksandr Zelichenko, Director.
Substance Abuse Treatment and HIV in Iran
Prevention, Treatment and Care of Hepatitis C among People Who Inject Drugs Jason Grebely, PhD Senior Lecturer Viral Hepatitis Clinical Research Program.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS H HIV Prevention for Female Sexual Partners of People Who Inject Drugs: Evaluation Results Theodore.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: June 2015.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Riga, 29 May 2008 Sintija Šmite, UNODC.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
International Harm Reduction Development Program: Lessons learned
MODULE 3 Harm reduction advocacy
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Cascade of care for people who use drugs - opportunities for integration and scale up of harm reduction services and other evidence based interventions.
Incarceration and People Who Inject Drugs in Ukraine: Modelling its Role in HIV Transmission and the Impact of Introducing OST in Prisons Jack Stone, Ellen.
Harm reduction in social and medical care for people who use drugs in the new environment Michel Kazatchkine UN Secretary General’s Special Envoy on HIV/AIDS.
The HIV/AIDS and drug use crisis in Eastern Europe and Central Asia
Needle and syringe exchange and working with injecting drug users
Pakistan Last updated: July 2015.
Global burden of HIV, viral hepatitis and TB in prisoners
Drug policy in Eastern Europe anya sarang
Global epidemiology of injecting drug use
Jack Stone, April Young, Jennifer R. Havens, Peter Vickerman
Modeling the potential impact of providing ART and OAT in prison and upon release on HIV incidence among PWID in Tijuana, Mexico Add other affiliations.
Harm Reduction at the Crossroads Drugs, drug policy, harm reduction: A reality check International AIDS Conference July 25, 2018 Amsterdam Daniel.
DRUG USE WORLDWIDE AND HIV
Modeling the impact of the Mexican drug law reform on HIV incidence among people who inject drugs (PWID) in Tijuana, Mexico. Add other affiliations for.
Coverage of HIV and HCV prevention interventions for people who inject drugs Dr Sarah Larney, Senior Research Fellow.
Towards a Conducive Legal and Structural Environment
Global Village Debate This house would ban information dissemination on safe injecting practices, and ban the provision of clean and sterile injecting.
The HIV Epidemic among People who Inject Drugs
The prevalence of non-fatal overdose among people who inject drugs
Myanmar Last Update: November 2014.
No conflicts of interest
Presentation transcript:

School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor Kate Dolan Program of International Research and Training National Drug and Alcohol Research Centre UNSW, Sydney, Australia

Policy and HIV epidemics Government Policy Restrict A) HIV prevention programs B) Scale up of effective HIV prevention

Policy restricts HIV prevention Case study Russia No Opiate Substitution Treatment Limited NSP 1,700,000 PWIDs - 37% HIV positive (666,000) Advocates pursuing legal action against the government – Russia’s ban on methadone has extended to Crimea

Policy restricts HIV prevention Case study of NSP in USA Ban on Federal funds for NSPs home and abroad Ban started in 1988 Repealed in 2009 Reinstated ,800,000 PWIDs - 16% HIV positive (280,000) If USA adopted NSP like Australia ~ 5,000 HIV infections avoided p.a.

Policy restricts HIV prevention 196 countries Countries without Community Programs Countries without Prison Programs No NSP No OST No ARV

Policy Restricts scale up of HIV prevention Coverage for PWIDs 2010 NSP % OST % ARV % Global estimate 8 8 4

Law enforcement and HIV epidemics Law enforcement increases the likelihood of sharing syringes incarceration of PWID increase HIV transmission

Law Enforcement: increases syringe sharing PWIDs arrested for drugs / confiscate syringes Drive drug users away from services Interrupt OST, ARV treatment Strathdee’s study on the Mexico US border HIV infection among female sex workers who injected was linked to syringe confiscation by the police

Law Enforcement: increase incarceration of PWID can increase HIV transmission Arrest, registry of drug users, report to police Leads to mass incarceration of PWIDs 30-60% vs. 1% Detained without access to prevention or treatment Numerous studies link HIV Infection to a history of incarceration Prevalent syringe sharing in prison, multiple partners, HIV outbreaks in prison Thailand, Russia, Iran, Lithuania

Recommend Drug treatment (esp. OST), NSP and ARV Educate on benefits of HR in and out of prison and harms of arresting and imprisoning PWIDs Work with police: refer to treatment, manage intoxicated offenders and Needle Stick Injury Shift resources from supply reduction to demand and harm reduction

References 1. Dolan, K. et al Needle and syringe programs: A review of the evidence. Australian Government Mathers et al. HIV prevention, treatment, care services for PWIDs Lancet, 2010; 375(9719): IHRA Global state of harm reduction Lurie, P & Drucker, E. An opportunity lost:. The Lancet,1997,349(9052): Dole, Methadone treatment of randomly selected criminal addicts NEJM, 1969;280(25): Hickman OST & HIV transmission in PWIDs: review and meta-analysis BMJ 2012;345:e Metzger, HIV seroconversion among ID in- and out-of-treatment: JAIDS, 1993;6(9):1049– Xing, Y, Economic evaluation of MMT in HIV/AIDS AIDS Care: 2012; 24(6): Dolan, K HIV/AIDS in prison: A global review of prevalence, incidence, mortality and HIV programs 10. Rhodes T, Situational factors influencing drug injecting, Soc Sci Med 2003;57(1): Sarang Policing drug users in Russia: risk, fear, structural violence. Subst Use Misuse, 2010; 45(6): Global commission on drug policy. The War on Drugs and HIV/AIDS How Criminalization of Drug Use Fuels the Global Pandemic, Strathdee HIV and risk environment for injecting drug users: the past, present, and future. Lancet, 2010; 376(9737): 14 Strathdee Social and structural factors associated with HIV infection among female sex workers who inject drugs in the Mexico-US border region. PloS one. 2011;6(4):e Pollini Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction (Abingdon, England). 2008;103(1): Dolan K, HIV in prison in low income & middle-income countries. Lancet Inf Dis, 2007;7(1):32-41.

Acknowledgements Anya Sarang, Dr Alex Wodak and Professor Michael Farrell